Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm.

Pons-Belda, Oscar D; Fernandez-Uriarte, Amaia; Diamandis, Eleftherios P

Pons-Belda, Oscar D; Fernandez-Uriarte, Amaia; Diamandis, Eleftherios P.

Afiliación

Pons-Belda OD; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada.
Fernandez-Uriarte A; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada.
Diamandis EP; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada.

Diagnostics (Basel) ; 11(12)2021 Nov 23.

Article en En | MEDLINE | ID: mdl-34943407

Palabras clave

cancer screening; circulating tumor DNA; clonal hematopoiesis; early cancer detection; liquid biopsy; molecular analysis; positive predictive value

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Screening_studies Idioma: En Revista: Diagnostics (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google